GENERIC NAME: loracarbef
BRAND NAME: (Lorabid: This brand no longer is available in the U.S. and there are no generic formulations.)
DRUG CLASS AND MECHANISM: Loracarbef is a synthetic oral antibiotic in the cephalosporin family of antibiotics. The cephalosporin family includes cephalexin (Keflex), cefaclor (Ceclor), cefuroxime (Zinacef), cefpodoxime (Vantin), cefprozil (Cefzil), and many injectable antibiotics. Like other cephalosporins, loracarbef stops bacteria from multiplying by preventing bacteria from forming the walls that surround them. The walls are necessary to protect bacteria from their environment and to keep the contents of the bacterial cell together. Bacteria cannot survive without a cell wall. Loracarbef is effective against a wide variety of bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, E. coli, and many others. Loracarbef was approved in December 1991.
GENERIC AVAILABLE: No
PREPARATIONS: Capsules: 200 and 400 mg. Suspension: 100 and 200 mg/5 ml.
STORAGE: Tablets and oral suspension may be stored at room temperature, 15 C to 30 C (59 F to 86 F) in a tightly closed container.
PRESCRIBED FOR: Loracarbef is effective against susceptible bacteria responsible for infections of the middle ear, tonsils, throat, larynx (laryngitis), bronchi (bronchitis), and sinuses as well as pneumonia. It also is used for treating urinary tract and skin infections.
Quick GuideSymptoms of Mono: Infectious Mononucleosis Treatment
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.